Marc Pflieger

Class I histone deacetylase inhibitor MS-275 attenuates vasoconstriction and inflammation in angiotensin II-induced hypertension

Yuhee Ryu, Hae Jin Kee, Simei Sun et al. · PLoS ONE · 2019 · 45 citations · Full text

Medicine, Cardiology, Pharmacology +17

Histone deacetylase inhibitor LMK235 attenuates vascular constriction and aortic remodelling in hypertension

Sin Young Choi, Hae Jin Kee, Simei Sun et al. · Journal of Cellular and Molecular Medicine · 2019 · 28 citations · Full text

Medicine, Cardiology, Pharmacology +17

High expression of CPT1b in skeletal muscle in metabolically healthy older subjects

Cécile Betry, Emmanuelle Meugnier, Marc Pflieger et al. · Diabetes & Metabolism · 2018 · 20 citations · Full text

Life Sciences, Biochemistry, Physiology +13

In Vitro Assessment of the Genotoxic Hazard of Novel Hydroxamic Acid- and Benzamide-Type Histone Deacetylase Inhibitors (HDACi)

Annabelle Friedrich, Ann-Sophie Assmann, Lena Schumacher et al. · International Journal of Molecular Sciences · 2020 · 18 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +12

QSAR Classification Models for Prediction of Hydroxamate Histone Deacetylase Inhibitor Activity against Malaria Parasites

Eva Hesping, Ming Jang Chua, Marc Pflieger et al. · ACS Infectious Diseases · 2022 · 13 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16